about
Exercise and NO production: relevance and implications in the cardiopulmonary systemAirway hyperresponsiveness in children with sickle cell anemia.Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell diseaseEnvironmental exposures, nitric oxide synthase genes, and exhaled nitric oxide in asthmatic children.Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).Arginase: marker, effector, or candidate gene for asthma?Host defense function of the airway epithelium in health and disease: clinical background.Nitric oxide metabolism in asthma pathophysiology.Animal models of allergic and inflammatory conjunctivitis.Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.Nitric oxide in health and disease of the respiratory system.Exhaled nitric oxide in paediatric asthma.Bench-to-bedside review: the role of nitric oxide in sepsis.Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor.Inhibition of anti-IgE mediated human mast cell activation by NO donors is dependent on their NO release kinetics.Is health-related quality of life associated with upper and lower airway inflammation in asthmatics?Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma.Protector mechanisms of the association between gastroesophageal reflux disease and asthma: experimental study in rats.Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways.Exhaled nitric oxide estimation by a simple and efficient noninvasive technique and its utility as a marker of airway inflammation in mice.Phenotypic alteration of neuropeptide-containing nerve fibres in seasonal intermittent allergic rhinitis.
P2860
Q27012707-3B0EEEF8-2068-4C1C-AB19-DB5FB64B5EB2Q30498301-18742E70-264D-4E56-BC01-1FDDBFAEDDA6Q30584222-5C1E5052-9994-46FC-B456-84F31B8E27E8Q33801295-A107A6B1-C47F-437A-ACD8-D5BA8E5D22ECQ35016089-E2288554-4374-46F8-B7D1-DBD5BE6F4EC8Q35095621-36847E34-F97F-4791-BFB4-EC32101261E5Q35218066-FC66E702-9F5E-4E6F-8B44-F411AC15AE58Q35435319-0D5F6303-FB72-47E7-983B-B6F5096C79BEQ35583047-E6A5C995-3E29-4548-ABC2-B3352C4732A4Q35597438-5FAD1548-7AF4-4DC4-8369-4ABB04A6BCB2Q35842979-0DD2946A-3DD3-45B6-B40D-6082C414AE13Q36310751-4597A0AC-D37B-4426-A9D7-FC709F170AAAQ37755037-8F172F37-F855-48A0-BB6F-CA3F7676FEB5Q38030379-B6FCBAAD-779C-47E6-B15B-F93E0776E720Q38857622-75058DD7-49CE-41CA-87B1-C25C92040611Q41425045-7E32BC7F-F963-40F4-A34B-BFDF6E700A2CQ42616838-ECD997AE-7E12-4A2F-B66A-63EAC2360ADEQ43031018-3D1FEC3D-5A75-4741-AEC1-1903EA41271CQ46318364-415A9D9F-632E-4432-B3B5-404228DB1888Q47776808-9984BE42-7F4D-44ED-B706-459947EA07B9Q47904927-7DFF617D-A48D-45C1-BB40-C319B406F457Q47956838-78F82644-8100-4E62-B3DA-7B048E7DF680
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mediators of asthma: nitric oxide.
@ast
Mediators of asthma: nitric oxide.
@en
Mediators of asthma: nitric oxide.
@nl
type
label
Mediators of asthma: nitric oxide.
@ast
Mediators of asthma: nitric oxide.
@en
Mediators of asthma: nitric oxide.
@nl
prefLabel
Mediators of asthma: nitric oxide.
@ast
Mediators of asthma: nitric oxide.
@en
Mediators of asthma: nitric oxide.
@nl
P2093
P356
P1476
Mediators of asthma: nitric oxide.
@en
P2093
Axel Fischer
Gert Folkerts
Pierangelo Geppetti
P356
10.1006/PUPT.2001.0332
P577
2002-01-01T00:00:00Z